Is TheStreet's Feurstein "Criminal," Or Is Pearlstein Being Misinterpreted?

TheStreet web site is demanding a retraction from the Washington Post, calling out a Post article that calls into question the ethics of one of TheStreet, Inc. (NASDAQ:TST) ’s reporters.

“You should immediately retract this defamatory story,” TheStreet’s Editor-in-Chief Janet Guyon said in the blog post that was longer than the original Post article. "This story is a hatchet job, unworthy of the Pulitzer-prize-winning Mr. Pearlstein, and unworthy of this venerable newspaper. We demand a retraction."

Washington Post's article implied TheStreet's Feurstein aiding short sellers

At issue is a Washington Post article implying that TheStreet’s biotech reporter, Adam Feurstein, was aiding short sellers in the stock of Northwest Biotherapeutics, Inc...